Browsing: biopharma nl

Since 2022, the Food and Drug Administration has been on a journey to reduce the reliance on animal testing in…

One of the standard treatments for idiopathic pulmonary fibrosis is an old drug that offers limited efficacy and a range…

For decades and despite calls for better diversity, the geography and population selection for pivotal trials in drugs has remained…

Roche is a relative latecomer in the chase to block a protein called KRAS G12C to treat lung cancer, but…

The recent attention surrounding hantavirus has understandably unsettled people. A virus associated with rodents, severe respiratory illness, and mortality rates…

Many blood cancers can be treated with a potentially curative stem cell transplant, but this procedure introduces a serious complication…

Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product…

Since 2019, roughly $60 billion has gone into using AI to discover drugs. About 175 AI-originated programs have entered human…

Ipsen has become an active dealmaker as it pursues growth in oncology, and its latest move is the $450 million…

A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this…